Subscribe to Search results

A witness with mild Haemophilia B was first given Factor 9 concentrate dental treatment at Royal Stoke Hospital. She did not know she was being given a blood product and was not told about any risks of infection.

Published on:

Nigel Hamilton stated in oral evidence that he and his brother were not given, nor were their parents, any information, warning or advice about the risks of blood-borne viruses associated with the use of factor concentrates

Published on:

Dr Elizabeth Mayne, at the Belfast Haemophilia Centre, gave those present the choice of whether they wanted to know the result of their HIV test

Published on:

A symptomatic carrier of Haemophilia B, was told that she had been infected with Hepatitis C at a routine check-up, in the middle of which she was asked "How are you coping with your hepatitis C?" She was unaware that she had been tested.

Published on:

A witness with mild Haemophilia B was given Factor 9 concentrate in 1980 for dental treatment at Royal Stoke Hospital. She did not know she was being given a blood product and was not told about any risks of infection.

Published on:

A witness was treated treatment with Factor 9 concentrates. She had said she did not want to receive it because of the fear of HIV but she was given it whilst drowsy from pre-med and felt that she was not given a real choice.

Published on:

A patient recalled in his witness statement to the inquiry that he had never been told of any associated risks when he was first given Factor VIII in 1983 or 1984 at the Royal Hallamshire Hospital

Published on:

In oral evidence Alice Mackie noted that the wife of a patient had recalled how her husband was always told there was nothing to worry about and that all blood donors had not had AIDS and that it had been safe

Published on:

In oral evidence Alice Mackie stated that the wife of a patient had recalled how they had believed that her husband had not been infected following a large group meeting as they had felt that had he been infected that they would have been told.

Published on:

There is evidence that blood was also taken from family members and used for research purposes, the nature of which remains unclear, with no explanation being given as to the purpose of the blood testing: see the evidence of Alice Mackie.

Published on:

Professor Christopher Ludlum explained that he had been unaware of the recommendations issued by the Council of Europe to avoid using coagulation factors

Published on:

Professor Christopher Ludlam confirmed that his handwriting had been on a first draft of the AIDS Advisory document written by Professor Bloom in which Bloom had asked for comments from Ludlam stating that recipients had not been informed of receiving an infected batch.

Published on:

It was not until 19 December 1984 (by which time Professor Ludlam had known the results for 16 patients, as well as a larger number of negative results, for nearly two months but had not told a single patient) that a group meeting took place to alert patients to what had happened. It was not until 1985 that the process of informing individual patients of their test results commenced

Published on:

Inquiry issues letter about compensation

Published on:

Inquiry round-up

Published on:

Inquiry receives letter from the Paymaster General

Published on:

In 1981 and 1982 Haemophilia A patients were primarily treated at the Royal Manchester Childrens' Hospital with commercial concentrate and no NHS concentrate was used at all.

Published on:

By September 1982, Cryoprecipitate tended to be used for hospital treatment and concentrates for home treatment at the Royal Manchester Childrens' Hospital .

Published on:

At the Royal Manchester Children's Hospital, parents were unaware that their children were being tested for HIV.

Published on:

Annual returns showed that there was no policy of restricting patients to single manufacturers or batches of commercial concentrate.

Published on: